| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals International, Plc (KNSA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. KNSA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 626.2K | $34.51M | - | |
| Other | 143.9K | $7.93M | - | |
| Dir | 36.5K | $2.01M | - | |
| COO | 28.7K | $1.58M | - | |
| CFO | 22.8K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 70,867 | $30.48 | $2,160,035.40 | -24.6% | +22.0% | +70.7% | |
| Jun 3, 2025 | Megna Michael R | Chief Accounting Officer | Sale+OE | 15,211 | $28.75 | $437,316.25 | -31.9% | +17.8% | +66.4% | |
| Jun 3, 2025 | Moat Ross | Chief Commercial Officer | Sale+OE | 27,594 | $29.02 | $800,777.88 | -74.6% | +17.8% | +66.4% | |
| Jun 3, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE | 18,299 | $28.80 | $527,011.20 | -40.4% | +17.8% | +66.4% | |
| May 28, 2025 | Patel Sanj K | Chairman &CEO | Sale+OE | 86,270 | $27.24 | $2,349,981.45 | -22.9% | +23.1% | +86.5% | |
| May 20, 2025 | Patel Sanj K | Chairman &CEO | Sale+OE | 2,349 | $27.02 | $63,469.98 | -2.4% | +26.3% | +103.3% | |
| May 19, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 12,000 | $26.41 | $316,920.00 | -14.2% | +26.1% | +99.5% | |
| May 13, 2025 | Patel Sanj K | Chairman &CEO | Sale+OE | 2,872 | $27.03 | $77,630.16 | -2.9% | +27.9% | +130.9% | |
| May 9, 2025 | Patel Sanj K | Chairman &CEO | Sale+OE | 8,095 | $27.04 | $218,866.45 | -2.7% | +27.2% | +125.1% | |
| May 7, 2025 | Paolini John F.51 | Chief Medical Officer | Sale+OE | 200 | $27.00 | $5,400.00 | -0.3% | +23.5% | +112.7% |